» Articles » PMID: 39387211

Improving Patient Outcomes in Acute and Subacute Stroke Using a Wearable Device-assisted Rehabilitation System: a Randomized Controlled Trial

Overview
Journal J Int Med Res
Publisher Sage Publications
Specialty General Medicine
Date 2024 Oct 10
PMID 39387211
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Multidisciplinary rehabilitation facilitates post-stroke functional recovery, but is associated with resource and accessibility barriers. This study evaluated the combination of a wearable device-assisted system (WEAR) and conventional therapy for post-stroke rehabilitation.

Methods: This randomized, controlled, parallel group, clinical trial was conducted at two rehabilitation centers. A WEAR system was developed featuring sensors and application program-embedded smartphones. Stroke patients within 12 weeks of onset and modified Rankin Scale (mRS) scores of 2 to 4 were randomized into a wearable group (WG, WEAR + conventional rehabilitation) or control group (CG, conventional rehabilitation) for 90 days. The primary outcome was mRS score changes within 90 days.

Results: Among 127 stroke patients enrolled (76 men [59.8%]; mean age: 57.5 years), 63 and 64 patients were randomized to WG and CG, respectively. Both groups showed significant improvements in mRS scores. Between-group repeated measures analysis adjusted for sex, age and number of rehabilitation sessions showed greater improvement in mRS scores within 90 days in the WG than in the CG (estimate: 0.73).

Conclusions: This combined WEAR and conventional rehabilitation approach may improve post-stroke functional recovery compared with conventional rehabilitation alone. The WEAR system permits remote monitoring and recording of rehabilitation in various settings.This clinical trial was retrospectively registered at www.clinicaltrials.gov with the Unique Identifier NCT04997408.

References
1.
Berge E, Whiteley W, Audebert H, De Marchis G, Fonseca A, Padiglioni C . European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke. Eur Stroke J. 2021; 6(1):I-LXII. PMC: 7995316. DOI: 10.1177/2396987321989865. View

2.
Leira E, Russman A, Biller J, Brown D, Bushnell C, Caso V . Preserving stroke care during the COVID-19 pandemic: Potential issues and solutions. Neurology. 2020; 95(3):124-133. PMC: 7455350. DOI: 10.1212/WNL.0000000000009713. View

3.
Van Den Berg M, Crotty Prof M, Liu E, Killington M, Kwakkel Prof G, Wegen E . Early Supported Discharge by Caregiver-Mediated Exercises and e-Health Support After Stroke: A Proof-of-Concept Trial. Stroke. 2016; 47(7):1885-92. DOI: 10.1161/STROKEAHA.116.013431. View

4.
Greenberg S, Ziai W, Cordonnier C, Dowlatshahi D, Francis B, Goldstein J . 2022 Guideline for the Management of Patients With Spontaneous Intracerebral Hemorrhage: A Guideline From the American Heart Association/American Stroke Association. Stroke. 2022; 53(7):e282-e361. DOI: 10.1161/STR.0000000000000407. View

5.
Liu C, Chen Y, Kittikowit S, Hongsuchon T, Chen Y . Using Unified Theory of Acceptance and Use of Technology to Evaluate the Impact of a Mobile Payment App on the Shopping Intention and Usage Behavior of Middle-Aged Customers. Front Psychol. 2022; 13:830842. PMC: 8927638. DOI: 10.3389/fpsyg.2022.830842. View